Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Clinical trial NCT06441110 · RECRUITING

Trial details

NCT number: NCT06441110
Sponsor: Fujian Medical University Union Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms BCG Vaccine Immunotherapy, Active Multicenter Study Treatment Outcome Neoplasm Recurrence, Local

Start date: 2023-06-01
Primary completion: 2025-06-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.